Dr Stephen Schleicher: COA Unique at Bringing Thought Leaders Together
AMCP 2023 to Feature Policy, Pharmaceutical Trends, Patient-Centered Outcomes
How Smoking, SES Are Linked With Allergic, Nonallergic Asthma Risk
AMCP 2023 Will Cover Biosimilars, Inflation Reduction Act, and Much More, Says Kimberly Westrich
Closed-Loop Insulin System Keeps Glucose Levels in Range Longer Than Standard Care in Children With Type 1 Diabetes
Study Shows Immune Response After COVID-19 Vaccine in Majority of Patients Treated With CAR T-Cell Therapy
What We’re Reading: Judge Questions Lawyers in Abortion Pill Case; Maternal Mortality Rises; Lobbying for Alzheimer Drugs
Trio of Scales Deemed Valid, Reliable for Use in Prurigo Nodularis
BMD Reduced, but Stable Throughout Course of Hemophilia, Say Findings
FMT Demonstrates Safety, Efficacy for Treatment of Recurrent CDI in Patients With IBD
Co-occurring Diabetes and Tooth Loss Linked to Worse, Faster Cognitive Decline
Racial, Ethnic, Socioeconomic Disparities Identified Among Patients With Cachexia at NSCLC Diagnosis
Dr David Eagle on Celebrating 20 Years of COA at This Year’s Meeting
PEPFAR Helps More Than 20 Million People With HIV Access ART Worldwide
Treatments for DED Associated With MGD Require Future Evaluation, Development
Pregnant Women With Epilepsy Experience Worse Perinatal Outcomes
Dr Edward Boyer on Evaluating the Toxic Impact of the Ohio Train Derailment
The Information Patients Receive During Multiple Myeloma Treatment May Differ From What They Want to Know
Greater Risk for Primary Hypertension Shown in Children of Most-Deprived Communities
What We’re Reading: Biomarker Testing in Kentucky; Opioid Guidelines Updated; EPA Limits in Drinking Water
Biden Administration Releases Drug Rebate List, Promotes End of Vaccine Cost Sharing
Dr Lee Norman on How the Pandemic Changed His Thoughts About Building Resilience
Small Device Improves Breathlessness in Patients With COPD
Accurate Remote Assessment of Psoriasis Possible From Patient Photographs, Questionnaire Responses, Study Finds
What We’re Reading: VA Will Cover Alzheimer Drug; Pfizer to Buy Seagen for $43B; Novo Nordisk to Cut Insulin Costs
Too Much, Too Little Sleep Linked With Greater Infection Risk
Treatment of Rare Anemias Shifting Rapidly
Ruxolitinib Reduces Posttransplant GVHD Risk in Pediatric β-Thalassemia Major
Contact Heterogeneity Could Produce Negative Vaccine Efficiency
What We’re Reading: Expanding Obesity Drug Coverage; UK Doctors Strike; Black Infant Deaths Surge